secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001493152-26-004154
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo completes oversubscribed tender offer, buys 300K shares at $3.50/share
------------------------------------------------------------------------------

- Final count: 4,907,881 shares tendered, oversubscribed.
- Accepted 300,000 shares (incl. 134,306 odd lots) at $3.50/share for ~$1.05M.
- Proration factor 3.47392%; accepted shares = 0.73% of shares outstanding.
- CEO: pleased to provide smaller stockholders opportunity to sell at premium to market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315226004154/0001493152-26-004154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315226004154/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer